pharmaphorum
JANUARY 4, 2021
Jennifer Haas, executive vice president of Noteworth, shares her 2021 predictions surrounding the future of telehealth and big data. . A recent report highlighted that over 40% of US adults had delayed seeing a doctor during the pandemic. The benefits of big data analytics range across the board in healthcare.
Pharma Marketing Network
NOVEMBER 11, 2020
Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. These changes include marketing processes, customer engagement, tools and tactics. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 8, 2022
Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .
Delveinsight
JULY 22, 2020
Since the data is collected for a long period of time, the doctor can easily evaluate the current and past medical conditions. New Insight/Data For Research. The data collected in the IoT can support medical research. The doctors need to analyse all the factors. Medical Information Distribution.
Delveinsight
FEBRUARY 17, 2021
The wearables collect and analyze users’ real-time medical data, which is more comfortable for physicians and doctors to examine. Key companies in the segment, such as Medtronic , Xiaomi , Huawei , Garmin , and Fitbit, offer many new devices to the user to dominate the evolving wearable market. Personalized Care.
pharmaphorum
MAY 30, 2022
“We can couple that with claims data and directly look at healthcare resource utilisation and see which doctors patients are visiting and if they are going to the emergency room or urgent care because of pain,” Sackman states. He oversees operations, including business development, sales and marketing, and people.
pharmaphorum
JULY 4, 2022
Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe.
Expert insights. Personalized for you.
111 
Let's personalize your content